Of Statistical Significance: "Trends" Toward Significance and Optimism Bias

Journal of the American College of Cardiology

Volumn 48, Issue 7, 2006, Pages 1471-

  Bangalore, Sripal ^a   Messerli, Franz H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VALSARTAN;

ANGINA PECTORIS; DRUG EFFECT; HEART INFARCTION; HUMAN; LETTER; MORBIDITY; PRIORITY JOURNAL; STROKE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLINICAL TRIALS; DATA INTERPRETATION, STATISTICAL; HUMANS; MYOCARDIAL INFARCTION; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 33748940231     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.07.011     Document Type: Letter

References (2)

1. McMurray J., Solomon S., Pieper K., et al. The effect of valsartan, captopril, or both on atherosclerotic events after acute myocardial infarction: an analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). J Am Coll Cardiol 47 (2006) 726-733
2. Chalmers I., and Matthews R. What are the implications of optimism bias in clinical research?. Lancet 367 (2006) 449-450